DRKS00011830
Recruiting
Not Applicable
Brain Metastases in Breast Cancer Network Germany (BMBC) - BMBC
Principal InvestigatorKlinik und Poliklinik für Gynäkologie Universitätsklinikum Hamburg-Eppendorf0 sites4,000 target enrollmentMarch 16, 2017
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Principal InvestigatorKlinik und Poliklinik für Gynäkologie Universitätsklinikum Hamburg-Eppendorf
- Enrollment
- 4000
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with brain metastases and a history of breast cancer,diagnosis of brain metastases since the year 2000\.
Exclusion Criteria
- •Patients with any other malignant disease, patients with no histological verification of the diagnosis of breast cancer, patients with a neurological disease, patients with exclusively leptomeningeal disease
Outcomes
Primary Outcomes
Not specified
Similar Trials
Withdrawn
Phase 2
Kadcyla In pAtients With bRAin MetastasisMetastatic HER2-positive Breast Cancer With Brain MetastasisNCT03203616Jules Bordet Institute
Unknown
Phase 2
Brain Metastases In ErbB2-Positive Breast CancerMetastatic Breast CancerJPRN-jRCT2080220279GlaxoSmithKline K.K.
Completed
Phase 3
Evaluation of the Efficacy of Hippocampal Avoidance on the Cognitive Toxicity of Whole-Brain Radiation Therapy After Surgical Resection of Single Brain Metastasis of Breast CancerBreast CancerBrain MetastasisNCT01942980Institut Paoli-Calmettes8
Recruiting
Not Applicable
Brain monitoring for high risk of brain metastases in metastatic breast cancerNeoplasmsKCT0003152Yonsei University Health System, Severance Hospital200
Completed
Not Applicable
Analysis of Brain Metastasis in Patients With Breast Cancer, With and Without Over-Expression of HER-2Breast NeoplasmsNCT00071383National Institute of Neurological Disorders and Stroke (NINDS)78